Skip to main content

Animations

MJFF Publications

1521 - 1530 of 9140 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2025
  • 2024
  • 2023
  • 2025
  • 2026
  • 2021
  • Summary Details
    OPEN
    Title: The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2021.754016
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28702
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Longitudinal Analysis of Brain-Predicted Age in Amnestic and Non-amnestic Sporadic Early-Onset Alzheimer's Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.729635
    Citation Count: 22
  • Summary Details
    OPEN
    Title: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28706
    Citation Count: 139
  • Summary Details
    OPEN
    Title: Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30196
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00259-024-06822-7
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Atrophy of the Cholinergic Basal Forebrain can Detect Presynaptic Cholinergic Loss in Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26596
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Data-driven characterization of distinct cognitive subtypes in Parkinson’s disease dementia
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-00970-9
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Accelerating Medicines Partnership® Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease Research
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.70183
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00174-x
    Citation Count: 45
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.